Home » International Drug Policy Consortium (IDPC) » Page 13

International Drug Policy Consortium (IDPC)

Item 11. Follow-up to the special session of the General Assembly on the world drug problem held in 2016, including the seven thematic areas of the outcome document of the special session (Afternoon session)

Indonesia: Nearly 3 years have passed since UNGASS – we have been committed to advancing promotion of human rights. In addressing the drug problems whilst protecting human rights the government has provided funding for therapy programmes for drug users and special needs populations such as women and children. It is important that human rights are …

Read more

Side Event: Aligning data collection with UNGASS implementation & the Sustainable Development Goals: Recommendations for a review of the Annual Report Questionnaire.

Organized by the Governments of Canada, Mexico and Switzerland, the International Drug Policy Consortium, the Centre on Drug Policy Evaluation, and the Global Drug Policy Observatory of Swansea University Vera Strickler (Switzerland): To analyse key trends on the global drug market it is crucial to have reliable and empirical based indicators that are in line with …

Read more

Side Event: Civil society on member state delegations to the CND: Models for engagement, benefits, and lessons learned

Organised by the Governments of Canada, Mexico and New Zealand, the International Drug Policy Consortium, the Centre of Drug Policy Evaluation, the New Zealand Drug Foundation, and the Canadian Drug Policy Coalition Zara Snapp, Instituto RIA I’ve been on the Mexican delegation foe the last 6-7 years, and wanted to share experiences. Some delegations, you …

Read more